Sebastian Klingen

Sebastian is specialised experience in advising domestic and foreign corporations on their (cross-border) M&A transactions and the corresponding pre- and post-merger measures as well as other general corporate matters.

Work Highlights

Transactions of significance where substantial involvement can be disclosed have included:

• Fresenius: on the acquisition of a majority stake (55%) in mAbxience, a leading supplier of biotechnologically produced generic medicines (biosimilars).
• Aperam: on the acquisition of ELG Haniel, a company active in the trading, processing and recycling of raw materials for the stainless steel industry and high-performance materials such as superalloys, titanium and carbon fibres.
• Covestro: on the acquisition of the Resins & Functional Materials business from Dutch Royal DSM.
• Mediahuis Group: on the acquisition of all shares in Aachener Verlagsgesellschaft mbH (AVG), and thereby a majority shareholding in Medienhaus Aachen GmbH, including the resulting joint venture with the existing minority shareholder of Medienhaus Aachen GmbH.
• STADA: on various strategic multi-national acquisitions of OTC brands.
• UBS: on the carve-out and cross-border transfer of its Spanish wealth management business to Singular Bank.
• Suzlon Energy Limited: on the sale of its German subsidiary Senvion SE to the US investment fund Centerbridge Partners
• LIXL: on its €3.059bn acquisition (together with Development Bank of Japan) of 87.5% of German-based Grohe Group from TPG Capital and Credit Suisse Private Equity.
  
   

Sebastian Klingen joined Linklaters in 2010 and was appointed Counsel in 2021.

Sebastian Klingen studied law at the University of Bielefeld. He also completed an Executive MBA in M&A at the Westfälische Wilhelms-Universität Münster. 

He speaks German and English.